Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer

Abstract Fibrosis with excessive amounts of type I collagen is a hallmark of many solid tumours, and fibrosis is a promising target in cancer therapy, but tools for its non-invasive quantification are missing. Here we used magnetic resonance imaging with a gadolinium-based probe targeted to type I c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Miloslav Polasek, Yan Yang, Daniel T. Schühle, Mohammad A. Yaseen, Young R. Kim, Yu Sub Sung, Alexander R. Guimaraes, Peter Caravan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d3d6d4e3ab7149cd8ad953c61bcdbb76
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d3d6d4e3ab7149cd8ad953c61bcdbb76
record_format dspace
spelling oai:doaj.org-article:d3d6d4e3ab7149cd8ad953c61bcdbb762021-12-02T12:32:45ZMolecular MR imaging of fibrosis in a mouse model of pancreatic cancer10.1038/s41598-017-08838-62045-2322https://doaj.org/article/d3d6d4e3ab7149cd8ad953c61bcdbb762017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-08838-6https://doaj.org/toc/2045-2322Abstract Fibrosis with excessive amounts of type I collagen is a hallmark of many solid tumours, and fibrosis is a promising target in cancer therapy, but tools for its non-invasive quantification are missing. Here we used magnetic resonance imaging with a gadolinium-based probe targeted to type I collagen (EP-3533) to image and quantify fibrosis in pancreatic ductal adenocarcinoma. An orthotopic syngeneic mouse model resulted in tumours with 2.3-fold higher collagen level compared to healthy pancreas. Animals were scanned at 4.7 T before, during and up to 60 min after i.v. injection of EP-3533, or of its non-binding isomer EP-3612. Ex-vivo quantification of gadolinium showed significantly higher uptake of EP-3533 compared to EP-3612 in tumours, but not in surrounding tissue (blood, muscle). Uptake of EP-3533 visualized in T1-weighted MRI correlated well with spatial distribution of collagen determined by second harmonic generation imaging. Differences in the tumour pharmacokinetic profiles of EP-3533 and EP-3612 were utilized to distinguish specific binding to tumour collagen from non-specific uptake. A model-free pharmacokinetic measurement based on area under the curve was identified as a robust imaging biomarker of fibrosis. Collagen-targeted molecular MRI with EP-3533 represents a new tool for non-invasive visualization and quantification of fibrosis in tumour tissue.Miloslav PolasekYan YangDaniel T. SchühleMohammad A. YaseenYoung R. KimYu Sub SungAlexander R. GuimaraesPeter CaravanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Miloslav Polasek
Yan Yang
Daniel T. Schühle
Mohammad A. Yaseen
Young R. Kim
Yu Sub Sung
Alexander R. Guimaraes
Peter Caravan
Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer
description Abstract Fibrosis with excessive amounts of type I collagen is a hallmark of many solid tumours, and fibrosis is a promising target in cancer therapy, but tools for its non-invasive quantification are missing. Here we used magnetic resonance imaging with a gadolinium-based probe targeted to type I collagen (EP-3533) to image and quantify fibrosis in pancreatic ductal adenocarcinoma. An orthotopic syngeneic mouse model resulted in tumours with 2.3-fold higher collagen level compared to healthy pancreas. Animals were scanned at 4.7 T before, during and up to 60 min after i.v. injection of EP-3533, or of its non-binding isomer EP-3612. Ex-vivo quantification of gadolinium showed significantly higher uptake of EP-3533 compared to EP-3612 in tumours, but not in surrounding tissue (blood, muscle). Uptake of EP-3533 visualized in T1-weighted MRI correlated well with spatial distribution of collagen determined by second harmonic generation imaging. Differences in the tumour pharmacokinetic profiles of EP-3533 and EP-3612 were utilized to distinguish specific binding to tumour collagen from non-specific uptake. A model-free pharmacokinetic measurement based on area under the curve was identified as a robust imaging biomarker of fibrosis. Collagen-targeted molecular MRI with EP-3533 represents a new tool for non-invasive visualization and quantification of fibrosis in tumour tissue.
format article
author Miloslav Polasek
Yan Yang
Daniel T. Schühle
Mohammad A. Yaseen
Young R. Kim
Yu Sub Sung
Alexander R. Guimaraes
Peter Caravan
author_facet Miloslav Polasek
Yan Yang
Daniel T. Schühle
Mohammad A. Yaseen
Young R. Kim
Yu Sub Sung
Alexander R. Guimaraes
Peter Caravan
author_sort Miloslav Polasek
title Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer
title_short Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer
title_full Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer
title_fullStr Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer
title_full_unstemmed Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer
title_sort molecular mr imaging of fibrosis in a mouse model of pancreatic cancer
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/d3d6d4e3ab7149cd8ad953c61bcdbb76
work_keys_str_mv AT miloslavpolasek molecularmrimagingoffibrosisinamousemodelofpancreaticcancer
AT yanyang molecularmrimagingoffibrosisinamousemodelofpancreaticcancer
AT danieltschuhle molecularmrimagingoffibrosisinamousemodelofpancreaticcancer
AT mohammadayaseen molecularmrimagingoffibrosisinamousemodelofpancreaticcancer
AT youngrkim molecularmrimagingoffibrosisinamousemodelofpancreaticcancer
AT yusubsung molecularmrimagingoffibrosisinamousemodelofpancreaticcancer
AT alexanderrguimaraes molecularmrimagingoffibrosisinamousemodelofpancreaticcancer
AT petercaravan molecularmrimagingoffibrosisinamousemodelofpancreaticcancer
_version_ 1718394008560992256